Why Asia’s future hinges on healthtech startups

Singapore’s healthcare technology sector has been on a hot streak.

Last year, the country’s healthtech startups raised US$409 million, with deal volume doubling from the previous year.

Across the globe, countries are grappling with aging populations, rising chronic disease burdens, and increasing healthcare costs. Yet, conventional healthcare systems struggle to meet these demands. That leaves room for startups that offer more efficient, cost-effective, and patient-centric solutions.

Image credit: Timmy Loen

Such startups harness innovations to tackle problems in traditional healthcare systems, which improves patient outcomes, widens access, and enhances quality of care.

The US has long been home to such innovations, and Europe has also seen significant growth in this area. Asia, with its vast population and diverse needs, has become fertile ground for healthcare startups.

See also: Mapping out SEA’s healthtech players

Singapore, China, India, and South Korea are particularly lush with opportunities, experiencing a surge in innovative ventures.

Filling the gap

Startups play a pivotal role in using cutting-edge technologies like AI to address complex healthcare challenges, including chronic disease management.

For instance, Singapore startup Awak Technologies has developed an AI prediction tool to help clinicians assess a patient’s risk of kidney disease progression and improve care.

Other startups are developing remote monitoring devices, smart medication dispensers, and personalized care platforms that let patients manage their conditions from the comfort of their homes.

A remote patient monitoring device by Biofourmis / Photo credit: Biofourmis

Boston-based Biofourmis has also developed tools to monitor patients at home and deliver care remotely. This not only improves the quality of life for those with chronic illnesses but also reduces the burden on healthcare facilities and professionals.

The struggle for funds

Investors’ social responsibility